| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.6M | — | -35.1% |
| SG&A Expense | $1.8M | — | +3.1% |
| Operating Income | -$3.4M | — | +16.0% |
| Income Tax | $0 | — | — |
| Net Income | -$3.3M | — | +16.4% |
| EPS (Basic) | -$0.22 | — | +66.7% |
| EPS (Diluted) | -$0.22 | — | +66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.5M | +218.3% | +141.1% |
| Current Assets | $47.2M | +203.6% | +138.2% |
| Total Assets | $47.6M | +198.8% | +135.4% |
| Current Liabilities | $5.3M | +91.6% | +57.6% |
| Stockholders' Equity | $41.6M | +234.3% | +167.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +24.1% |
| Financing Cash Flow | $34.6M | — | — |